TMCnet News
IndexIQ To Transfer Exchange Listing of Leaders in Research & Development ETF Suite To NasdaqIndexIQ today announced plans to transfer the listing of the Leaders in Research & Development ETF Suite from NYSE Arca to Nasdaq on or around October 18th, 2022. The three funds that will be transferred are:
Investors in the funds should not expect to see any meaningful impact on their trading experience as a result of the transfer. LRND, MRND, and WRND seek to track to the price and yield performance of the IQ U.S. Large Cap R&D Leaders Index, IQ U.S. Mid Cap R&D Leaders Index, and IQ Global Equity R&D Leaders Index (together the "Indexes"), respectively. These funds are designed to offer exposure to companies that have a history of consistently reinvesting into their research and development activities, either domestically or globally, positioning themselves for future innovations and the expansion of existing capabilities. IndexIQ is continually working to diversify the exchanges on which its ETFs trade. With this ongoing partnership, IndexIQ seeks to better serve our clients through optimizing our ETF offerings. Many of IndexIQ's ETFs remain listed at NYSE Arca and we continue to view NYSE Arca as a valued and dependable partner for our funds For more information on the fund and on IndexIQ's full suite of ETF offerings, please visit our website here.
About IndexIQ
Disclosures About Risk: IQ Global Equity R&D Leaders ETF / IQ U.S. Mid Cap R&D Leaders ETF / IQ U.S. Large Cap R&D Leaders ETF Principal Risks
Equity Securities Risk
New Fund Risk
Non-Diversified Risk
Industry/Sector Concentration Risk.
IQ U.S. Mid Cap R&D Leaders ETF Mid-Capitalization Companies Risk. Mid-capitalization companies may be more vulnerable to adverse general market or economic developments, and their securities may be less liquid and may experience greater price volatility than larger, more established companies. IQ U.S. Large Cap R&D Leaders ETF
Large-Capitalization Companies Risk
IQ Global Equity R&D Leaders ETF
Foreign Securities Risk
Investing involves risk, including possible loss of principal. Asset allocation and diversification may not protect against market risk, loss of principal, or volatility of returns. There is no guarantee that these investment strategies will work under all market conditions or are suitable for all investors, and each investor should evaluate their ability to invest long-term, especially during periods of downturn in the market. No representation is being made that any account, product, or strategy will or is likely to achieve profits. This material has been prepared for informational purposes only, and is not intended to provide, and should not be relied on for, accounting, legal or tax advice. Your clients should consult your tax or legal advisor regarding such matters. This material is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. Consider the Funds' investment objectives, risks, charges and expenses carefully before investing. The prospectus and the statement of additional information include this and other relevant information about the Funds and are available by visiting IQetfs.com. Read the prospectus carefully before investing. IndexIQ® is the indirect wholly owned subsidiary of New York Life Investment Management Holdings LLC and serves as the advisor to the IndexIQ ETFs. ALPS Distributors, Inc. (ALPS) is the principal underwriter of the ETFs, and NYLIFE Distributors LLC is a distributor of the ETFs. NYLIFE Distributors LLC is located at 30 Hudson Street, Jersey City, NJ 07302. ALPS Distributors, Inc. is not affiliated with NYLIFE Distributors LLC. NYLIFE Distributors LLC is a Member FINRA/SIPC. "New York Life Investments" is both a service mark, and the common trade name, of certain investment advisors affiliated with New York Life Insurance Company.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220929005119/en/ |